Development of paediatric medicines: concepts and principles

Area of Science:

• Pediatric Pharmacology
• Drug Development
• Regulatory Science

Background:

• Historically, pediatric drug labeling lagged behind adult use, leading to common off-label prescriptions.
• The emergence of mandatory safety and efficacy trials for drug approval is a relatively recent development.
• Increased understanding of pediatric physiology, pharmacokinetics, and pharmacodynamics highlights the need for child-specific data.

Purpose of the Study:

• To provide historical context for the off-label use of drugs in children.
• To examine the driving forces and institutions involved in improving pediatric drug efficacy and safety.
• To assess the progress and future outlook for pediatric medicine development.

Main Methods:

• Historical review of drug regulation and pediatric pharmacology.
• Analysis of institutional involvement (legislators, regulatory authorities, pharmaceutical companies, WHO).
• Examination of scientific advancements in understanding child development and disease processes.

Main Results:

• Legislation mandating drug safety and efficacy trials has shaped modern pharmaceutical practice.
• Multidisciplinary efforts involving various institutions are crucial for advancing pediatric medicine.
• Despite challenges in a market-driven economy, significant progress is being made.

Conclusions:

• Understanding child physiology and disease processes is key to improving pediatric drug therapy.
• Collaborative efforts among scientists, regulators, and healthcare professionals are driving progress.
• Children are increasingly benefiting from advancements in pharmaceutical research and regulation.